Previously treated cases tested for RR-/MDR-TB (%) in Argentina
Argentina: Previously treated cases tested for RR-/MDR-TB was 61.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Argentina, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Argentina stood at 61.0%.
Compared with earlier readings it is up 10.9% on the previous year and up 48.8% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Argentina peaked at 100.0% in 2005 and was at its lowest, 0.0%, in 2011.
That places Argentina 136th out of 180 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Argentina, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 100.0% | — |
| 2011 | 0.0% | -100.0% |
| 2013 | 54.0% | — |
| 2014 | 41.0% | -24.1% |
| 2015 | 15.0% | -63.4% |
| 2016 | 2.3% | -84.7% |
| 2017 | 31.0% | +1247.8% |
| 2018 | 40.0% | +29.0% |
| 2019 | 67.0% | +67.5% |
| 2020 | 34.0% | -49.3% |
| 2021 | 47.0% | +38.2% |
| 2022 | 45.0% | -4.3% |
| 2023 | 55.0% | +22.2% |
| 2024 | 61.0% | +10.9% |
Argentina compared with similar countries
- Argentina's 61.0% is below the median for upper middle income countries, which is 92.0%, 66% of the median. (52 countries reporting)
- Argentina's 61.0% is below the median for Latin America & Caribbean, which is 85.0%, 72% of the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Argentina changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2017 | +1247.8% | 2.3% | 31.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 100.0% | 1 |
| 2010s | 31.3% | 0.0% | 67.0% | 8 |
| 2020s | 48.4% | 34.0% | 61.0% | 5 |
Countries ranked near Argentina
- 134 Madagascar 69.0% compare
- 135 Costa Rica 62.0% compare
- 136 Panama 61.0% compare
- 136 Cuba 61.0% compare
- 136 Austria 61.0% compare
More health data for Argentina
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6333 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,462 deaths per 1,000 people (2090)
- Number of infants who die before age 1 684 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.7 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0269 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.7 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Argentina?
- Previously treated cases tested for rr-/mdr-tb in Argentina was 61.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Argentina?
- The highest recorded value was 100.0% in 2005.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Argentina?
- The lowest recorded value was 0.0% in 2011.
- How does Argentina rank for previously treated cases tested for rr-/mdr-tb?
- Argentina ranks 136th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Argentina?
- Over the last ten years it is up 48.8%. The long-run trend across the full record is volatile.
- Where does this Argentina data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).